Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-18

Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating EXPAREL (bupivacaine liposome injectable suspension) with or without adjunct bupivacaine HCl for postsurgical analgesia in lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE)
  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Lower Extremity Surgery, Bunion | Phase 3 | Status: COMPLETED | Results posted: 2022-07-18